Atyr Pharma Inc [NASDAQ: ATYR] gained 3.73% or 0.21 points to close at $5.84 with a heavy trading volume of 3708496 shares.
It opened the trading session at $5.68, the shares rose to $5.93 and dropped to $5.65, the range by which the price of stock traded the whole day. The daily chart for ATYR points out that the company has recorded 77.51% gains over the past six months.
If we look at the average trading volume of 2.43M shares, ATYR reached to a volume of 3708496 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Atyr Pharma Inc [ATYR]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ATYR shares is $19.35 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ATYR stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Leerink Partners have made an estimate for Atyr Pharma Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on February 18, 2025. While these analysts kept the previous recommendation, Cantor Fitzgerald raised their target price to Overweight. The new note on the price target was released on January 06, 2025, representing the official price target for Atyr Pharma Inc stock. Previously, the target price had yet another raise to $17, while Wells Fargo analysts kept a Overweight rating on ATYR stock.
The Price to Book ratio for the last quarter was 6.93, with the Price to Cash per share for the same quarter was set at 0.86.
Trading performance analysis for ATYR stock
Atyr Pharma Inc [ATYR] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 5.61. With this latest performance, ATYR shares gained by 12.31% in over the last four-week period, additionally plugging by 77.51% over the last 6 months – not to mention a rise of 61.33% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ATYR stock in for the last two-week period is set at 66.24, with the RSI for the last a single of trading hit 0.37, and the three-weeks RSI is set at 0.37 for Atyr Pharma Inc [ATYR]. The present Moving Average for the last 50 days of trading for this stock 4.63, while it was recorded at 5.53 for the last single week of trading, and 3.61 for the last 200 days.
Atyr Pharma Inc [ATYR]: A deeper dive into fundamental analysis
Return on Equity for this stock declined to -60.25%, with Return on Assets sitting at -60.25%. When it comes to the capital structure of this company, Atyr Pharma Inc [ATYR] has a Total Debt to Total Equity ratio set at 0.17.
Reflecting on the efficiency of the workforce at the company, Atyr Pharma Inc [ATYR] managed to generate an average of -$1074745.76 per employee.Atyr Pharma Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 7.79 and a Current Ratio set at 7.79.
An analysis of Institutional ownership at Atyr Pharma Inc [ATYR]
There are presently around $69.63%, or 71.22% of ATYR stock, in the hands of institutional investors.
